Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1027-1033

  Van Dijk, Jeroen P ^a   Knops, Gertrudis H J N ^a   Van De Locht, Louis T F ^a   Menke, Aswin L ^a   Jansen, Joop H ^a   Mensink, Ewald J B M ^a   Raymakers, Reinier A P ^a   De Witte, Theo ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Differentiation; Haematopoiesis; MDS; Transcription factor; WT1

Indexed keywords

CD34 ANTIGEN; MESSENGER RNA; RHODAMINE 123;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW DISEASE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DYSERYTHROPOIESIS; ERYTHROID CELL; GENE; GENE EXPRESSION; GENETIC ANALYSIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MORPHOLOGY; MYELODYSPLASIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WT1 GENE;

ACUTE DISEASE; ANTIGENS, CD34; BONE MARROW CELLS; CELL DIFFERENTIATION; GENE EXPRESSION; HUMANS; LEUKEMIA, MYELOID; MYELODYSPLASTIC SYNDROMES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; WT1 PROTEINS;

EID: 0036046115     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03728.x     Document Type: Article

References (42)

1. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis
2. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
3. Overexpression of murine WT1 +/+ and -/- isoforms has no effect on chemoresistance but delays differentiation in the K562 leukemia cell line
4. The possible role and application of WT1 in human leukemia
5. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain
6. The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells
7. Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow
8. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor
9. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
10. Alternative splicing and genomic structure of the Wilms tumor gene WT1
11. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation
12. The Wilms tumor suppressor gene wt1 is required for development of the spleen
13. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia
14. Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells
15. Genomic changes in the WT-gene (WT1) in Wilms' tumors and their correlation with histology
16. Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance
17. Mutations in the Wilms' tumor gene WT1 in leukemias
18. WT-1 is required for early kidney development
19. Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression
20. Homozygous deletion of a DNA marker from chromosome 11p13 in sporadic Wilms tumor
21. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro
22. Wilms tumor gene (wt1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors
23. Wilms' tumor: A developmental anomaly
24. The Wilms' tumor 1 gene: Oncogene or tumor suppressor gene?
25. Expression of the Wilms' tumor gene (WT1) in human leukemias
26. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis
27. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus
28. WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia
29. Wilms' tumor gene. WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells
30. An improvement of the single-step method of RNA isolation by acid thiocyanate-phenol-chloroform extraction
31. Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells
32. Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer
33. Studies of the human c-myb gene and its product in human acute leukemias
34. A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicity
35. Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells
36. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice
37. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program
38. Downregulation of Wilms' tumor gene (WT1) is not a prerequisite for erythroid or megakaryocytic differentiation of the leukemic cell line K562
39. Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)
40. Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123
41. Differential expression of the amv gene in human hematopoietic cells
42. Trans-activation of an intronic hematopoietic-specific enhancer of the human Wilms' tumor 1 gene by GATA-1 and c-Myb